Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 8, 2012, Pages 1174-1181

  Ma, Qing ^a   Li, Dan ^a   Nurieva, Roza ^a   Patenia, Rebecca ^a   Bassett, Roland ^a   Cao, Wei ^a   Alekseev, Andrei M ^a   He, Hong ^a   Molldrem, Jeffrey J ^a   Kroll, Michael H ^a   Champlin, Richard E ^a   Sale, George E ^b   Afshar Kharghan, Vahid ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Alloimmune responses; Dendritic cell; T lymphocyte; The complement system

Indexed keywords

CD8ALPHA ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW TRANSPLANTATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MALE; MESENTERY LYMPH NODE; MORTALITY; MOUSE; NONHUMAN; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; COMPLEMENT C3; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; TH1 CELLS; TH17 CELLS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864022365     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.05.014     Document Type: Article

References (42)

1. Appelbaum F.R. Haematopoietic cell transplantation as immunotherapy. Nature 2001, 411:385-389.
2. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 2007, 7:340-352.
3. Blazar B.R., Korngold R., Vallera D.A. Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 1997, 57:79-109.
4. Korngold R., Friedman T.M. Murine models for graft-versus-host disease. Thomas' Hematopoietic Cell Transplantation 2004, 353-368. Blackwell Scientific, Boston. K.G. Blume, S.J. Forman, F.R. Appelbaum (Eds.).
5. Sale G.E., Shulman H.M., Hackman R.C. Pathology of hematopoietic cell transplantation. Thomas' Hematopoietic Cell Transplantation 2004, 286-299. Blackwell Scientific, Boston. K.G. Blume, S.J. Forman, F.R. Appelbaum (Eds.).
6. Ferrara J.L.M., Cooke K.R., Teshima T. The pathophysiology of graft-vs-host disease. Graft-vs-Host Disease 2005, 1-34. Marcel Dekker, New York. 3rd ed. J.L.M. Ferrara, K.R. Cooke, H.J. Deeg (Eds.).
7. Longhi M.P., Harris C.L., Morgan B.P., et al. Holding T cells in check: a new role for complement regulators?. Trends Immunol 2006, 27:102-108.
8. Sacks S.H. Complement fragments C3a and C5a: the salt and pepper of the immune response. Eur J Immunol 2010, 40:668-670.
9. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat Rev Immunol 2007, 7:9-18.
10. Carroll M.C. The complement system in regulation of adaptive immunity. Nat Immunol 2004, 5:981-986.
11. Raedler H., Yang M., Lalli P.N., et al. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant 2009, 9:1784-1795.
12. Peng Q., Li K., Anderson K., et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008, 111:2452-2461.
13. + T cells. Immunity 2008, 28:425-435.
14. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002, 8:582-587.
15. Zhou W., Patel H., Li K., et al. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 2006, 107:2461-2469.
16. Zhou W., Medof M.E., Heeger P.S., et al. Graft-derived complement as a mediator of transplant injury. Curr Opin Immunol 2007, 19:569-576.
17. Jacquier-Sarlin M.R., Gabert F.M., Villiers M.B., et al. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 1995, 84:164-170.
18. Reis E.S., Barbuto J.A., Kohl J., et al. Impaired dendritic cell differentiation and maturation in the absence of C3. Mol Immunol 2008, 45:1952-1962.
19. Kerekes K., Cooper P.D., Prechl J., et al. Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells. J Leukoc Biol 2001, 69:69-74.
20. Peng Q., Li K., Patel H., et al. Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol 2006, 176:3330-3341.
21. Lalli P.N., Strainic M.G., Lin F., et al. Decay accelerating factor can control T cell differentiation into IFN-γ-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol 2007, 179:5793-5802.
22. Niculescu F., Niculescu T., Nguyen P., et al. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs-host disease. Exp Mol Pathol 2005, 79:136-145.
23. El-Amouri I.S., Bani-Ahmad M., Tang-Feldman Y., et al. Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression. Clin Exp Immunol 2010, 162:379-391.
24. Taylor P.A., Ehrhardt M.J., Lees C.J., et al. Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood 2007, 110:3480-3488.
25. Blazar B.R., Taylor P.A., McElmurry R., et al. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 1998, 92:3949-3959.
26. Nurieva R., Yang X.O., Chung Y., et al. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J Immunol 2009, 182:2565-2568.
27. + T cells, the cytokines they generate, and GVHD: something old and something new. Blood 2011, 117:3268-3276.
28. Fowler D., Gress R. Graft-versus-host disease as a Th1-type process: regulation by donor cells of Th2 cytokine phenotype. Graft-vs-Host Disease 1997, 479-500. Marcel Dekker, New York. J. Ferrara, H. Deeg, S. Burakoff (Eds.).
29. Hashimoto M., Hirota K., Yoshitomi H., et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 2010, 207:1135-1143.
30. Fang C., Zhang X., Miwa T., et al. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 2009, 114:1005-1015.
31. Nurieva R.I., Chung Y., Hwang D., et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149.
32. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
33. Geissmann F., Manz M.G., Jung S., et al. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
34. + dendritic cells. J Exp Med 2010, 207:1131-1134.
35. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415.
36. Ordemann R., Hutchinson R., Friedman J., et al. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002, 109:1249-1256.
37. Duffner U.A., Maeda Y., Cooke K.R., et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004, 172:7393-7398.
38. + T cells to elicit hepatic graft-versus-host disease. J Immunol 2002, 169:7111-7118.
39. Chan G.W., Gorgun G., Miller K.B., et al. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:170-176.
40. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999, 189:587-592.
41. -) dendritic cells in vivo. J Exp Med 2002, 196:817-827.
42. Woodruff T.M., Nandakumar K.S., Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol 2001, 48:1631-1642.